The Plan for Pitt: Engage in Research of Impact

The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Douglas J. Weber, associate...
Salk administering a shot to a nurse
April 12 marks 65 years since the polio vaccine, developed by a team led by Pitt’s Jonas Salk, was deemed safe and effective. Its success helped move vaccine science forward, and gives hope for a COVID-19 vaccine today.
A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched this week at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies and waiting until they are tested in longer clinical trials?
Götz Veser
When labs at the Swanson School of Engineering closed for research purposes, Götz Veser (pictured), the Nickolas DeCecco...
A person in a white coat and black tie holds a patch on their finger
University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.
Douglas White
Douglas White, professor in the Department of Critical Care Medicine and director of its Program on Ethics and Decision Making in Critical Illness, published a new framework that helps hospitals ethically allocate scarce critical care resources such as ventilators during the pandemic.
Paul Duprex in a suit and green tie
The Coalition for Epidemic Preparedness Innovations is committing nearly $5 million to a consortium that includes the University of Pittsburgh’s Center for Vaccine Research to develop a vaccine for the novel coronavirus.